The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Persistence of androgen receptor (AR) expression in patients (pts) with small cell prostate cancer (SCPC): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).
 
Rahul Raj Aggarwal
No Relationships to Disclose
 
Jack Youngren
No Relationships to Disclose
 
Artem Sokolov
No Relationships to Disclose
 
Jiaoti Huang
No Relationships to Disclose
 
George Thomas
Research Funding - Agios
 
Adam Foye
No Relationships to Disclose
 
Joshi J. Alumkal
Consulting or Advisory Role - Gilead Sciences
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); ImClone Systems (Inst); Millennium (Inst); Novartis (Inst)
 
Charles J. Ryan
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Bayer; Millennium
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis
 
Tomasz M. Beer
Stock and Other Ownership Interests - Salarius Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Novartis; Sotio
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Research & Development (Inst); Medivation (Inst); OncoGenex (Inst); Sotio (Inst)
 
Christopher P. Evans
Stock and Other Ownership Interests - Medivation; Oncogenex
Honoraria - Janssen Oncology; Medivation; Sanofi
Consulting or Advisory Role - Janssen Oncology; Medivation; Millennium
Speakers' Bureau - Janssen Oncology; Medivation; Sanofi
Research Funding - Medivation
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology; Medivation; Sanofi
 
Martin Gleave
Employment - OncoGenex
Stock and Other Ownership Interests - OncoGenex
Honoraria - Janssen, Astellas
Consulting or Advisory Role - Amgen; OncoGenex, Janssen, Astellas, AstraZeneca, Bayer
Speakers' Bureau - Janssen, Atellas
Research Funding - Janssen, Astellas
Travel, Accommodations, Expenses - Amgen
 
Matthew Rettig
Consulting or Advisory Role - Bayer
Speakers' Bureau - Johnson & Johnson
Research Funding - GlaxoSmithKline
 
Eric Jay Small
No Relationships to Disclose